Literature DB >> 7961510

Characterization of CMP-N-acetylneuraminic acid synthetase of group B streptococci.

R F Haft1, M R Wessels.   

Abstract

The capsular polysaccharide is a critical virulence factor for group B streptococci associated with human infections, yet little is known about capsule biosynthesis. We detected CMP-Neu5Ac synthetase, the enzyme which activates N-acetylneuraminic acid (Neu5Ac, or sialic acid) for transfer to the nascent capsular polysaccharide, in multiple group B streptococcus serotypes, all of which elaborate capsules containing Neu5Ac. CMP-Neu5Ac synthetase isolated from a high-producing type Ib strain was purified 87-fold. The enzyme had apparent Km values of 7.6 for Neu5Ac and 1.4 for CTP and a pH optimum of 8.3 to 9.4, required magnesium, and was stimulated by dithiothreitol. This is the first characterization of an enzyme involved in group B streptococcus capsular polysaccharide biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961510      PMCID: PMC197127          DOI: 10.1128/jb.176.23.7372-7374.1994

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  PURIFICATION AND PROPERTIES OF THE CMP-N-ACETYLNEURAMINIC ACID SYNTHESIZING ENZYME FROM SHEEP BRAIN.

Authors:  M SHOYAB; T N PATTABIRAMAN; B K BACHHAWAT
Journal:  J Neurochem       Date:  1964-09       Impact factor: 5.372

2.  Purification, properties, and genetic location of Escherichia coli cytidine 5'-monophosphate N-acetylneuraminic acid synthetase.

Authors:  W F Vann; R P Silver; C Abeijon; K Chang; W Aaronson; A Sutton; C W Finn; W Lindner; M Kotsatos
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

3.  Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.

Authors:  H J Jennings; E Katzenellenbogen; C Lugowski; D L Kasper
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

4.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.

Authors:  M S Edwards; D L Kasper; H J Jennings; C J Baker; A Nicholson-Weller
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.

Authors:  M R Wessels; J L DiFabio; V J Benedì; D L Kasper; F Michon; J R Brisson; J Jelínková; H J Jennings
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

6.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.

Authors:  M B Marques; D L Kasper; M K Pangburn; M R Wessels
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.

Authors:  M R Wessels; V Pozsgay; D L Kasper; H J Jennings
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

9.  Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.

Authors:  M R Wessels; R F Haft; L M Heggen; C E Rubens
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  CMP-N-acetylneuraminic acid synthetase of Escherichia coli: high level expression, purification and use in the enzymatic synthesis of CMP-N-acetylneuraminic acid and CMP-neuraminic acid derivatives.

Authors:  S L Shames; E S Simon; C W Christopher; W Schmid; G M Whitesides; L L Yang
Journal:  Glycobiology       Date:  1991-03       Impact factor: 4.313

View more
  6 in total

1.  O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.

Authors:  Shannon Weiman; Satoshi Uchiyama; Feng-Ying C Lin; Donald Chaffin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

2.  Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.

Authors:  Aaron F Carlin; Amanda L Lewis; Ajit Varki; Victor Nizet
Journal:  J Bacteriol       Date:  2006-09-22       Impact factor: 3.490

3.  Kinetic properties of the acylneuraminate cytidylyltransferase from Pasteurella haemolytica A2.

Authors:  I G Bravo; S Barrallo; M A Ferrero; L B Rodríguez-Aparicio; H Martínez-Blanco; A Reglero
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

4.  Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.

Authors:  Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

5.  Identification and characterization of important residues in the catalytic mechanism of CMP-Neu5Ac synthetase from Neisseria meningitidis.

Authors:  Louise E Horsfall; Adam Nelson; Alan Berry
Journal:  FEBS J       Date:  2010-05-20       Impact factor: 5.542

6.  Sialic Acid-Like Sugars in Archaea: Legionaminic Acid Biosynthesis in the Halophile Halorubrum sp. PV6.

Authors:  Marianna Zaretsky; Elina Roine; Jerry Eichler
Journal:  Front Microbiol       Date:  2018-09-07       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.